Completed NA INTERVENTIONAL 4-arm NCT04704440

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil (HEXAS)

Hemodynamic Effects of Acute Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension: Single-center Randomized Controlled Trial

Sponsor: University of Zurich

Conditions Hypertension, Pulmonary

Interventions Normobaric hypoxia (FiO2 15%) Normobaric hypoxia (FiO2 15%) under Sildenafil Placebo-ambient air (FiO2 21%) Placebo-ambient air (FiO2 21%) under Sildenafil

Updated 7 times since 2021 Last updated: Jun 5, 2023 Started: Feb 1, 2021 Primary completion: May 31, 2023 Completion: May 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04704440, this NA trial focuses on Hypertension, Pulmonary and remains completed. Sponsored by University of Zurich, it has been updated 7 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2022 — Jul 2023 [monthly]

Recruiting NA
May 2021 — Jun 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Mar 2021 — May 2021 [monthly]

Not Yet Recruiting NA
Feb 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Zurich

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland